We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
122 hedge funds and large institutions have $324M invested in Anika Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 49 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
7% more funds holding
Funds holding: 114 → 122 (+8)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more call options, than puts
Call options by funds: $5K | Put options by funds: $5K
0.62% less ownership
Funds ownership: 89.09% → 88.47% (-0.62%)
4% less capital invested
Capital invested by funds: $335M → $324M (-$11.8M)
29% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 49
Holders
122
Holders Change
+8
Holders Change %
+7.02%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
35
Reduced
49
Closed
6
Calls
$5K
Puts
$5K
Net Calls
–
Net Calls Change
+$59K
Top Buyers
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.99M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.52M |
| 3 |
Morgan Stanley
New York
|
-$1.27M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.22M |
| 5 |
VIA
Virtus Investment Advisers
Hartford,
Connecticut
|
-$1.15M |
